Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2026-02-25 @ 11:04 PM
Study NCT ID:
NCT00625404
Status:
COMPLETED
Last Update Posted:
2018-07-26
First Post:
2008-02-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women
Sponsor:
FHI 360
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HIV Infections | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Aspartate Aminotransferase (AST) | View |
| None | Alanine Aminotransferase (ALT) | View |
| None | HIV | View |
| None | HIV Prevention | View |
| None | Oral PrEP | View |
| None | Truvada | View |
| None | women | View |
| None | Tenofovir | View |
| None | TDF | View |
| None | FTC | View |
| None | emtricitabine | View |
| None | hepatitis | View |
| None | Pre-exposure Prophylaxis (PrEP) | View |
| None | HIV Seronegativity | View |